Impact of antiretroviral therapy on the course and outcome of suppurative lung and pleural disease in HIV-infected patients

DOI: https://doi.org/10.29296/25877305-2020-07-08
Download full text PDF
Issue: 
7
Year: 
2020

P. Ionov(1); Professor A. Elkin(2), MD; G. Yakovlev(1); I. Deinega(1), Candidate of Medical
Sciences (1)City Pokrovskaya Hospital, Saint Petersburg (2)City Tuberculosis Hospital Two, Saint Petersburg

The paper considers the impact of antiretroviral therapy (ARVT) on the course and outcome of suppurative lung and pleural diseases (SLPD) in HIV-infected patients. It defines the nature of lung and pleura lesions and determines CD4 lymphocyte counts and viral load depending on the use of ARVT. There are data on surgical interventions and outcomes of SLPD.
Keywords: 
pulmonology
infectious diseases
suppurative lung and pleural diseases
HIV infection
CD4 lymphocytes
HIV load

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Donati K. De Gaetano, Bertagnolio S., Tumbarello M. et al. Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected subjects. Int J Antimicrob Agents. 2000; 16: 357–60. DOI: 10.1016/s0924-8579(00)00265-x
  2. Fisk D., Meshnick S., Kazanjian P. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin Infect Dis. 2003; 36: 70–8. DOI: 10.1086/344951
  3. Kaye-Eddie G., Black A. Comparison of empyema thoracis in HIV-infected and non-infected patients with regard to aetiology and outcome. South Afr J Epidemiol Infect. 2012; 27 (4): 189–94. https://doi.org/10.1080/10158782.2012.11441507
  4. Riquet M., Hubsch J., Chehab A. Thoracic empyema in HIV-infected patients. J Chest. 1999; 115 (4): 1219–20. DOI: 10.1378/chest.115.4.1219
  5. Sullivan J., Moore R., Keruly J. et al. Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection. Am J Respir Crit Care Med. 2000; 162: 64–7. DOI: 10.1164/ajrccm.162.1.9904101
  6. Moskaleva E.V., Petrova A.G., Smirnova S.V. VICh-infektsija u detej s pozitsii klinicheskoj immunologii. Sib med zhurn. 2006; 9: 105–8 [Moskaleva E.V., Petrova A.G., Smirnova S.V. HIV-infection in children from the position of clinical immunology. Sibirskij medicinskij zhurnal. 2006; 9: 105–8 (in Russ.)].
  7. Deeks S., Verdin E., McCune J. Immunosenescence and HIV. Curr Opin Immunol. 2012; 24 (4): 501–6. DOI: 10.1016/j.coi.2012.05.004
  8. Massanella M., Negredo E., Perez-Alvarez N. et al. CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART. AIDS. 2010; 24 (7): 959–68.
  9. Putov N.V. Ostrye infektsionnye destruktsii legkih. Zabolevanija organov dyhanija. Pod red. M.M. Il'kovicha. SPb: Nord-Izdat, 1998; s. 388–420 [Putov N.V. Ostrye infekcionnye destrukcii legkih. Zabolevaniya organov dyhaniya. Pod red. M.M. Il’kovicha. SPb: Nord-Izdat, 1998; s. 388–420 (in Russ.)].
  10. Medvenskij B.V. Ostrye infektsionnye destruktsii legkih: Sovremennye predstavlenija ob etiologii i patogeneze, otsenka metodov lechenija. Avtoref. dis. ... d-ra med. nauk. SPb, 1993; 36 s. [Medvenskij B.V. Ostrye infekcionnye destrukcii legkih: Sovremennye predstavleniya ob etiologii i patogeneze, ocenka metodov lecheniya. Avtoref. dis. ... d-ra med. nauk. SPb, 1993; s. 36 (in Russ.)].